{"id":"W4417009494","doi":"10.1182/blood-2025-4058","title":"Safety and efficacy of elranatamab + nirogacestat in patients with relapsed or refractory multiple myeloma: Results from the Phase 1b MagnetisMM-4 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Refractory (planetary science); Multiple myeloma; Phases of clinical research; Bone marrow; Bortezomib; Progressive disease; Logistic regression","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001921499,0.001016016,0.001986933,0.0004246481,0.0003777874,0.0008797403,0.0007413811,0.0009612991,0.002548304],"category_scores_gemma":[0.001035388,0.0003532628,0.002083931,0.0004379913,0.0004765856,0.0006996738,0.0003754388,0.002115477,0.0007287776],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001100554,"about_ca_system_score_gemma":0.0009228293,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005894568,"about_ca_topic_score_gemma":0.001305009,"domain_scores_codex":[0.9993098,0.0003646665,0.00004402599,0.0001138868,0.00007872748,0.00008883722],"domain_scores_gemma":[0.9992275,0.0001369107,0.0002543099,0.00005835805,0.00005855786,0.0002642925],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6613638,0.02647514,0.06063884,0.001307423,0.007893904,0.000426106,0.0002402634,0.003655293,0.04189124,0.000247343,0.008638383,0.1872223],"study_design_scores_gemma":[0.4453273,0.3888268,0.1373658,0.0001386523,0.00531898,0.0008275837,0.0001223363,0.003302322,0.007417769,0.0007106363,0.01054886,0.00009287037],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897378,0.006006123,0.0002718646,0.0005414354,0.00008114214,0.000453731,0.001565577,0.00007912669,0.001263161],"genre_scores_gemma":[0.9908192,0.002058876,0.000701447,0.001008405,0.0001853372,0.0006981872,0.003143279,0.00002942209,0.001355805],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002548304,"threshold_uncertainty_score":0.010162,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01447195926172965,"score_gpt":0.2906162230157695,"score_spread":0.2761442637540398,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}